Benzinga

Benzinga

Benzinga

venerdì, agosto 21

Arbutus Biopharma Corp

ABUSNASDAQ
Trade with Public
Trade with Public
$5.21
0.449.22%
In chiusura: Aug 21, 5:00 PM EST
$5.23
0.02080.4%
Post-mercato: 6:12 PM EST
PRO
Perché si muove?:Arbutus Biopharma shares are trading higher after the company announced pla...
PanoramicaNotiziePrevisioni utiliEventiObiettivi di prezzoDati finanziariSentimentAzionariatoConfrontaOpzioniRapporto azionario

Arbutus Biopharma Analyst Price Targets

Wall Street analyst price targets and consensus rating for Arbutus Biopharma (ABUS).

Price Target Range — 8 Quarters

Analyst Consensus — 4 Analysts

1S.Buy
3Buy
Consensus RatingBuy# Analysts4Avg. Consensus PT$6Upside to Avg. PT+5.1%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →
DateFirmAnalystActionRating ChangePrice Target
Nov 14, 2025Chardan CapitalKeay NakaeMaintainedBuy$5
Aug 11, 2025Chardan CapitalKeay NakaeMaintainedBuy$5
More with Benzinga EdgeGet Access

Analyst Ratings News

Moderna's $950 Million Settlement Clears Legal Overhang, Stock Soars

Moderna shares jump after a $950 million settlement over COVID-19 vaccine patents, easing investor concerns and clearing legal uncertainty.
Vandana Singh

PRO
Chardan Capital Maintains Buy on Arbutus Biopharma, Maintains $5 Price Target

Chardan Capital analyst Keay Nakae maintains Arbutus Biopharma (NASDAQ:ABUS) with a Buy and maintains $5 price target.
Benzinga Newsdesk

PRO
Chardan Capital Maintains Buy on Arbutus Biopharma, Maintains $5 Price Target

Chardan Capital analyst Keay Nakae maintains Arbutus Biopharma (NASDAQ:ABUS) with a Buy and maintains $5 price target.
Benzinga Newsdesk

PRO
Chardan Capital Maintains Buy on Arbutus Biopharma, Maintains $5 Price Target

Chardan Capital analyst Keay Nakae maintains Arbutus Biopharma (NASDAQ:ABUS) with a Buy and maintains $5 price target.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Arbutus Biopharma, Maintains $5 Price Target

HC Wainwright & Co. analyst Ed Arce reiterates Arbutus Biopharma (NASDAQ:ABUS) with a Buy and maintains $5 price target.
Benzinga Newsdesk

Walmart To Rally More Than 15%? Here Are 10 Top Analyst Forecasts For Wednesday

Avi Kapoor

Dati e API: API Benzinga · API notizie azionarie · API valutazioni analisti · API logo aziende

Dati di mercato forniti da API Benzinga

Benzinga

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

© 2026 Benzinga | All Rights Reserved